Spirometer Market is estimated to be valued at USD 1,511.3 Mn in 2026 and is expected to reach USD 2,889.4 Mn in 2033, exhibiting a compound annual growth rate (CAGR) of 9.7% from 2026 to 2033.
Increasing incidences of diseases like COPD, asthma, pulmonary fibrosis, and cystic fibrosis are some of the factors boosting the growth of the spirometer market. Growing awareness about the importance of early diagnosis of lung diseases, growing expenditure on healthcare, and the development of new techniques in pulmonary function testing are the other major factors driving the growth of the market. The use of respiratory monitoring at home and preventative healthcare programs are some of the factors contributing to the growth of the market. Nevertheless, lack of awareness in the developing countries and the expensive nature of the equipment are some of the factors limiting the growth of the market.
Based on Product Type, the Table Top Spirometer is set to be dominant in 2026 because of its varied applications in diagnosing and managing the respiratory ailments of COPD, asthma, and other forms of pulmonary disease. The accuracy of these types of instruments, their comprehensive testing ability, and their widespread usage makes them dominate the market.
Based on Technology Type, the Flow Measurement category is set to be dominant in 2026. This is because flow measurement technology has many applications in pulmonary testing and is used as a method of obtaining accurate and precise measures of lung capacity and airflow obstruction in patients.
Based on Application, the Chronic Obstructive Pulmonary Disease (COPD) category is set to dominate the market in 2026, owing to the increase in the prevalence of COPD around the world and the demand for early diagnosis and treatment of the condition. Based on End User, the Hospitals and Clinics category is set to be dominant in 2026.
Regionally, North America is poised to lead the spirometer market with a projected market share of 35.4% in 2026 owing to the presence of well-developed healthcare infrastructure, high awareness levels about respiratory disorders, and strategic mergers and collaborations between key players operating in the industry. Growing investments in pulmonary diagnostics and respiratory care have further boosted the regional dominance.
Prominent Players in the Spirometer Market
1. Koninklijke Philips N.V.
Company Overview
- Headquarters: Amsterdam, Netherlands
- Establishment Year: 1891
- Employee Strength: Approximately 67,000 employees
- Leadership: Roy Jakobs, Chief Executive Officer
- Core Services/Products: Diagnostic imaging systems, respiratory care solutions, patient monitoring devices, spirometry systems, and connected healthcare technologies.
SWOT Analysis
- Strengths
- Significant presence in the field of health care technology and respiratory care internationally.
- Wide range of offerings for diagnostics and monitoring.
- Weaknesses
- Faced with risks related to quality and regulatory compliance issues.
- Reliant on large healthcare capital equipment markets.
- Opportunities
- Increasing need for respiratory diagnostic instruments.
- High demand for connected and digital health care solutions.
- Threats
- Stiff competition in medical devices industry.
- Changing regulations around the world.
-
SCHILLER AG
Company Overview
- Headquarters: Baar, Switzerland
- Establishment Year: 1974
- Employee Strength: Approximately 1,400 employees
- Leadership: Alfred E. Schiller, Founder & Chief Executive Officer
- Core Services/Products: Spirometry systems, pulmonary diagnostics, ECG devices, patient monitoring systems, and cardiopulmonary diagnostic solutions.
SWOT Analysis
- Strengths
- Very good knowledge about cardiopulmonary diagnostics techniques.
- Solid name in spirometry and pulmonary tests.
- Weaknesses
- Bigger scope on the international stage than that of leading healthcare companies.
- Lack of diversification other than diagnostic equipment.
- Opportunities
- Rising demand for pulmonary function testing.
- Development of preventive respiratory healthcare initiatives.
- Threats
- Competition from large manufacturers of diagnostic devices.
- Financial constraints in the healthcare sector.
-
Midmark Corporation
Company Overview
- Headquarters: Versailles, Ohio, U.S.
- Establishment Year: 1915
- Employee Strength: Approximately 2,200 employees
- Leadership: Jon Wells, President & Chief Executive Officer
- Core Services/Products: Medical equipment, diagnostic devices, spirometry solutions, workflow technologies, and clinical care systems.
SWOT Analysis
- Strengths
- Firmly established in ambulatory care and outpatient care environments.
- Extensive product range in clinical workflow and diagnostics.
- Weaknesses
- More focused on the North American market.
- Lesser international exposure than competing multinationals.
- Opportunities
- Emerging need for point-of-care respiratory diagnostics.
- More outpatient and primary care provision.
- Threats
- Growing competitive pressure in diagnostics equipment.
- Economic challenges in healthcare budgets.
-
Smiths Medical
Company Overview
- Headquarters: Minneapolis, Minnesota, U.S.
- Establishment Year: 1940
- Employee Strength: Approximately 8,000 employees
- Leadership: Brian Roberts, Chief Executive Officer
- Core Services/Products: Respiratory care devices, infusion systems, airway management products, patient monitoring solutions, and medical consumables.
SWOT Analysis
- Strengths
- Respiratory and critical care products have a good reputation.
- Large global distribution network.
- Weaknesses
- Concentration on hospitals and acute care settings.
- Vulnerable to product recall and compliance issues.
- Opportunities
- Surge in requirement of respiratory monitoring systems.
- Increase in home health care and chronic care management.
- Threats
- Medical devices stringent regulations.
- Competitions from diversified medical technology firms.
-
Vyaire Medical, Inc.
Company Overview
- Headquarters: Mettawa, Illinois, U.S.
- Establishment Year: 2016
- Employee Strength: Approximately 4,000 employees
- Leadership: Craig Snyder, Chief Executive Officer
- Core Services/Products: Spirometry systems, pulmonary function testing equipment, respiratory diagnostics, ventilation solutions, and respiratory care technologies.
SWOT Analysis
- Strengths
- Niche approach towards respiratory disease diagnosis and treatment.
- Variety of pulmonary function test offerings.
- Weaknesses
- Increased vulnerability to the performance of the respiratory care market.
- Lesser diversification than big players in the medical devices industry.
- Opportunities
- Increasing instances of respiratory ailments throughout the world.
- Increasing uptake of pulmonary diagnosis technologies.
- Threats
- Competition from international healthcare corporations.
- Regulatory and reimbursement issues in key markets.
